PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Bendroflumethiazide - Hypertension

PAD Profile : Bendroflumethiazide - Hypertension

Keywords :
Thiazide diuretics, bendrofluazide

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Tablets
Important Information :
Indapamide is the preferred diuretic treatment option. No requirement to switch from bendroflumethiazide in stable patients.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Thiazide-like diuretics such as Indapamide or chlorthalidone are the preferred option for patients requiring a diuretic for hypertension as per NICE Clinical Guideline 127.

However for people who are already having treatment with bendroflumethiazide and whose blood pressure is stable and well controlled, continue treatment with the bendroflumethiazide.

Note: 2.5mg produces a maximal blood pressure lowering effect, with very little biochemical disturbance

Associated BNF Codes

02. Cardiovascular System
02.02.01. Thiazides and related diuretics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More